CAMEO+ eventCORPORATE2026-04-21馃嚭馃嚫
Ray Therapeutics raises upsized $125 million Series B for vision restoration
source: Ray Therapeutics
On 2026-04-21, Ray Therapeutics announced an upsized and oversubscribed $125 million Series B financing for its vision restoration treatments. The company said the round supports its lead clinical program, RTx-015, and follows recent FDA RMAT designation.
0.21Significance4.0Magnitude0.3Systemic0.2Market1Articles
Location
San FranciscoCaliforniaNorth AmericaUnited StatesNorth America37.775, -122.419
Story Links